ImmuCell Corp. (Nasdaq: ICCC), a Portland-based biotech company that makes health products for cattle, on Monday reported financial results that showed a 46% sales increase for the first quarter of 2022, compared with the same period in 2021.
Last quarter’s total hit a record high for the company, reaching $6 million, and continuing a trend that included a 45% sales increase for Q4 2021. Read more
The Bar Harbor Planning Board has approved a plan by the Jackson Laboratory to build a 20,000-square-foot expansion to its Rare Disease Translational...
Researchers at Bigelow Laboratory for Ocean Sciences believe algae can make a big splash in the agricultural, aquaculture and pharmaceutical industries,...
The University of Maine System said this week it will work with a national consultant to study the feasibility of launching the state’s...